版本:
中国

BRIEF-Novan presents preclinical data from inflammatory skin diseases program

April 27 Novan Inc:

* Novan presents preclinical data from inflammatory skin diseases program

* Novan -in a psoriasis mouse model, SB414 significantly reduced composite psoriasis scores and also inhibited production of pro-inflammatory cytokines Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐